UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 13 | Issue 3 | March 2026

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 11 Issue 12
December-2024
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2412056


Registration ID:
551849

Page Number

a624-a633

Share This Article


Jetir RMS

Title

Bronchial Asthma

Abstract

Wheezing, briefness of breath, casket miserliness, and coughing are symptoms of bronchial asthma, a condition of the airways that causes swelling and narrowing. Children's asthma is influenced by a complex interplay of factors, including the severity of the condition, how the children respond to it, the effectiveness of therapy, social roles, and the social environment. Dust, animal dander, weather variations, pollution, mold, pollen, respiratory infections, stress, and tobacco smoking are the most frequent causes of bronchial asthma. Inflammation and airway remodeling, including goblet cell hyperplasia, subepithelial fibrosis, collagen deposition, mucosal gland hyperplasia, smooth muscle hypertrophy, and extracellular matrix alterations, are the primary pathophysiological features of asthma. When diagnosing asthma, spirometry measures lung function, and pulse oximetry tracks oxygen saturation, which quantifies the quantity of arterial hemoglobin that is used in conjunction with oxygen) to diagnose bronchial asthma. Restoring normal respiratory function while avoiding symptoms, exacerbations, or side effects is the aim of asthma treatment. The sympathomimetic medications known as beta 2 agonists cause "selective" activation of beta 2 adrenergic receptors, which facilitates bronchodilation and alleviates bronchospasm. It is necessary to increase the number of controller agents when short actin beta 2 agonists are used as a substitute five or more times per day. For oral asthma treatment, prednisone and prednisolone are the recommended glucocorticoids. Because methylxanthines can inhibit phosphodiesterase, which causes bronchodilatation, they are frequently used to treat asthma. When theophylline is first used orally, gastrointestinal side side goods similar nausea and puking might do. likewise, poisonous symptoms can develop into arrhythmia and tachycardia.

Key Words

Bronchial asthma; Diagnosis; Etiology; Pathophysiology; Management

Cite This Article

"Bronchial Asthma", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 12, page no.a624-a633, December-2024, Available :http://www.jetir.org/papers/JETIR2412056.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Bronchial Asthma", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 12, page no. ppa624-a633, December-2024, Available at : http://www.jetir.org/papers/JETIR2412056.pdf

Publication Details

Published Paper ID: JETIR2412056
Registration ID: 551849
Published In: Volume 11 | Issue 12 | Year December-2024
DOI (Digital Object Identifier):
Page No: a624-a633
Country: Kangra, Himachal Pradesh, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000301

Print This Page

Current Call For Paper

Jetir RMS